By Dr. Jennifer Frangos, D.O.
Quick answer: Trials support testosterone for one thing in women past menopause: low sexual desire that bothers you. No testosterone product is FDA approved for menopause symptoms or low desire in women, so any prescription is off label or compounded. Trials have not shown a benefit for general wellbeing, mood, brain fog, bone or muscle, and testosterone has barely been studied in perimenopause.
Is testosterone FDA approved for women?
Not for menopause. A 2026 FDA notice says that, unlike estrogen, there are no FDA-approved uses of testosterone for menopausal women, yet off-label use among women near or after menopause has grown over the past decade. The agency scheduled a public workshop for September 17, 2026, on the evidence and what is still unknown. The workshop was not an approval decision.
So US prescribers use either a product made for men, adjusted for women, or a compounded one.
Symptom by symptom: what the trials found
The main evidence is a 2019 review that pooled 36 randomized trials with 8,480 women. A statement built on that review, the Global Consensus Position Statement, was endorsed by international medical societies including the Endocrine Society and The North American Menopause Society (now The Menopause Society).
| Symptom or goal | What trials in postmenopausal women found | Verdict |
|---|---|---|
| Low sexual desire that bothers you | About one more satisfying sexual experience a month than placebo, and less distress | Benefit shown |
| General wellbeing | No effect | No benefit shown |
| Low mood | No effect on depressed mood | No benefit shown |
| Brain fog, thinking and memory | Insufficient evidence | Not enough data |
| Bone density | No effect at 12 months | No benefit shown |
| Muscle and body composition | No significant effect, in few studies | No benefit shown |
| Hot flashes and night sweats | Not addressed in the consensus statement. Estrogen-based hormone therapy remains the most effective option | Not a supported use |
Sources: Global Consensus Position Statement on the Use of Testosterone Therapy for Women (2019). Hot flash row: The North American Menopause Society 2022 hormone therapy position statement.
The benefit was shown in women past menopause whose low desire bothered them and had no other clear cause. Doctors call this hypoactive sexual desire disorder, or HSDD. Energy is a benefit often promised online, and it is not among the effects trials have shown. NICE in the UK takes the same narrow view: consider testosterone for low sexual desire if HRT alone is not effective.
Perimenopause: the least studied group
If you still have periods, the evidence gets thinner. The Global Consensus found insufficient data to make any recommendation for premenopausal women, and it does not address perimenopause separately. A 2021 guideline from the International Society for the Study of Women’s Sexual Health (ISSWSH) allowed for treating low desire before menopause, while noting that the data are limited to women in the late reproductive years and come from small trials.
Whether testosterone helps in perimenopause is unknown. The large trials that would show how often it helps, and for which symptoms, have not been done. If it is offered to you at this stage, it is reasonable to ask what it is meant to treat and how you’ll both know whether it is working. If you aren’t sure which stage you’re in, start with how perimenopause is diagnosed.
Does menopause itself lower testosterone?
Less than most people assume, at least for natural menopause. The FDA notes that testosterone declines with age, with levels in a woman’s late 40s about half of what they were in her early 20s, and it also lists testosterone among the ovarian hormones that fall with menopause. A cross-sectional study that recruited 1,423 women aged 18 to 75 points to age more than menopause: it found that menopause did not, by itself, change testosterone levels in women aged 45 to 54. The exception was women 55 and older who had both ovaries removed, whose testosterone was significantly lower.
A blood test can’t tell you whether testosterone will help. The Global Consensus states that no blood level cutoff separates women with low desire from women without it. A baseline level is still worth having, as a starting point for monitoring. Our guide to normal testosterone levels in women explains the ranges.
Cream, injection or pellet: what the guidelines say
The trials behind the one benefit shown kept blood levels in the range of women before menopause, mostly with testosterone given through the skin. Neither the Global Consensus nor the ISSWSH guideline recommends oral testosterone. The consensus advises against any form, pellets and injections included, that pushes levels above the female range, and against compounded testosterone unless no approved equivalent is available. The ISSWSH document is stricter: it does not recommend intramuscular injections or pellets, and it says compounded products cannot be recommended because efficacy and safety data are lacking. Where no product for women exists, both accept an approved product made for men, adjusted for women (ISSWSH specifies a through-the-skin product).
At Amazing Meds, testosterone for women is prescribed as a cream or an injection. The ISSWSH guideline does not recommend intramuscular injections and does not cover other injection routes, so prescribing an injection goes beyond that guideline. Whichever form you are offered, by us or anyone else, ask what blood level the prescriber is aiming for and how often it will be checked. We compare the two forms in testosterone cream vs injections for women.
Side effects and what isn’t known
At female-range levels, in trials lasting up to 24 months, some women had mild acne and more body or facial hair. Testosterone at those levels was not linked to scalp hair loss, voice change or clitoral enlargement. When levels run above the female range, the ISSWSH guideline lists voice deepening and scalp hair thinning among the risks.
Long-term safety is the larger unknown. Safety data at these levels extend only to 24 months, and long-term effects on the heart and breast have not been established. The FDA’s 2026 workshop was called in part to examine these gaps.
Does insurance pay for testosterone?
Often not for the medication, because of its FDA status. The visit and the labs are separate questions. The details are in does insurance cover testosterone for women.
Testosterone care at Amazing Meds
Care starts with a free call with our care team, who check your insurance benefits. For testosterone, labs always come first, followed by a telehealth visit with a provider.
We bill insurance for provider visits and labs when we’re in network with your plan. We don’t accept Medicare or Medicaid. Medication is self-pay, a care manager gives you the price before anything is ordered, and HSA and FSA cards are accepted. Refills are automatic: a provider reviews each one and a heads-up email arrives first, so you can reply to pause, change or stop anytime.
The full step-by-step is on How Amazing Meds Works.
Frequently asked questions
Is prescribing testosterone off label allowed?
Yes. The FDA says providers generally may prescribe an approved drug for an unapproved use when they judge it medically appropriate. Off label also means the FDA has not determined that testosterone is safe and effective for that use.
How long does testosterone take to work for low desire?
For women who respond, the ISSWSH guideline says benefit appears on average at about 6 to 8 weeks, with the full effect on desire at around 12 weeks. If there is no meaningful improvement by 6 months, the guideline says treatment should not continue.
Will testosterone give me more energy?
Trials have not shown that. The Global Consensus found no effect on general wellbeing in postmenopausal women, and the only benefit it found enough evidence for was low sexual desire.
Can I take testosterone along with estrogen?
They can be prescribed together. NICE suggests considering testosterone for low sexual desire when HRT alone has not been effective. Whether that fits your history is a question for your provider.
Medical disclaimer: This article is for general education and isn’t medical advice. Testosterone is a prescription medication with risks, and it is not right for everyone. Talk with a qualified clinician before starting, stopping or changing any hormone therapy.